Diagnostic Imaging Technologies provide imagery feedback on a patient's physical condition, which is then used to diagnose, monitor or treat medical conditions, thus playing an important role in improving public health of all age groups. X-ray based examinations are crucial in all medical settings and are utilised at every level. While practicing preventive as well as curative medicine, effective medical decisions require precise diagnostics, which technological advancements have significantly enhanced.

These technological advancements initially started out with simple X-rays but have now revolutionized medical care in terms of diagnostics. Radiography, MRIs, CT scans, ultrasound, etc. have created a strong market in this field proving to be valuable and necessary investments are pouring in. Newer technologies have made diagnosis less invasive and more accurate, for example elastography tests the elasticity of organs, tactile sensing technology helps in minimum invasive surgery etc.

This market is one of the few markets that have seen strong growth in both developed, and developing countries with significant investments specifically from hospitals, all over the globe. Medical Imaging and Technology Alliance (MITA), a branch of National Electrical Manufacturing Association (NEMA) is a collective representation of this market's R&D developers, manufacturers and innovators.

Data from developing countries over the years indicate that number of invasive surgeries could have been avoided, if simple diagnostic imaging had been accessible. The most evident challenge faced by this market is its high cost of usage, resulting in a substantial percentage of patients being unable to afford it. This discourages hospitals with limited budgets to invest in this technology. Lack of awareness in rural areas and unwillingness to trust technology also is a restraint for the overall growth of this market.

Key Topics Covered:

1. Executive Summary

2. Emerging Diagnostic Imaging Technologies: Introduction
2.1. Diagnostic Imaging
2.2. Market Definition

3. Market Overview
3.1. Market definition
3.2. Recent innovations and clinical trials
3.3. Conventional versus emerging diagnostic imaging technologies
3.4. Regulatory framework by geography
3.5. Key buying criteria
3.6. Top market analysis
3.7. End user analysis
3.8. Stakeholder analysis and supply chain management
3.9. Key findings
3.10. Strategic Recommendation

4. Drivers of Diagnostic Imaging Technologies

5. Restraints of Diagnostic Imaging Technologies

6. Opportunities of Diagnostic Imaging Technologies

7. Challenges of Diagnostic Imaging Technologies

8. Segmentation
8.1. Radiography
8.2. MRI
8.3. Nuclear Medicine
8.4. Ultrasound
8.5. Elastography
8.6. Tactile imaging
8.7. Photoacoustic imaging
8.8. Thermography
8.9. Tomography
8.10. Echocardiography
8.11. Functional near-infrared spectrography
8.12. Other emerging technologies

9. Competitive Landscape
9.1. Key Service Provider
9.2. Key Strategies
9.3. Market Growth and Shares
9.4. Market Forecast

10. Geography Analysis
10.1. North America
10.1.1. U.S.
10.1.2. Canada
10.2. Europe
10.2.1. UK
10.2.2. France
10.2.3. Germany
10.2.4. Italy
10.2.5. RoE
10.3. APAC
10.3.1. India
10.3.2. Japan
10.3.3. Korea
10.3.4. China
10.3.5. RoAPAC
10.4. ROW

11. Company Profiling
11.1. Lumenis Ltd.
11.2. Biolase
11.3. Photomedex
11.4. IRIDEX corporation
11.5. Spectranetics Corporation
11.6. Other companies

For more information visit http://www.researchandmarkets.com/research/825zsc/emerging

Media Contact: Laura Wood , +353-1-481-1716, Email Contact

To view the original version on PR Newswire, visit: http://www.prnewswire.com/news-releases/emerging-diagnostic-imaging-nuclear-imaging-systems-3d-imaging-tactile-imaging-tomography-emerging-diagnostic-biomarkers-wearable-diagnostic-devices-market---forecast-and-opportunities-to-2020-300024215.html

SOURCE Research and Markets